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Odds ratios for head and neck cancer increase with greater cigarette and alcohol use and lower body mass index
(BMI; weight (kg)/height2 (m2)). Using data from the International Head and Neck Cancer Epidemiology Consor-
tium, the authors conducted a formal analysis of BMI as a modifier of smoking- and alcohol-related effects. Analysis
of never and current smokers included 6,333 cases, while analysis of never drinkers and consumers of10 drinks/
day included 8,452 cases. There were 8,000 or more controls, depending on the analysis. Odds ratios for all sites
increased with lower BMI, greater smoking, and greater drinking. In polytomous regression, odds ratios for BMI
(P¼ 0.65), smoking (P¼ 0.52), and drinking (P¼ 0.73) were homogeneous for oral cavity and pharyngeal cancers.
Odds ratios for BMI and drinking were greater for oral cavity/pharyngeal cancer (P < 0.01), while smoking odds
ratios were greater for laryngeal cancer (P< 0.01). Lower BMI enhanced smoking- and drinking-related odds ratios
for oral cavity/pharyngeal cancer (P < 0.01), while BMI did not modify smoking and drinking odds ratios for
laryngeal cancer. The increased odds ratios for all sites with low BMI may suggest related carcinogenic mecha-
nisms; however, BMI modification of smoking and drinking odds ratios for cancer of the oral cavity/pharynx but not
larynx cancer suggests additional factors specific to oral cavity/pharynx cancer.
alcohol drinking; body mass index; laryngeal neoplasms; models, statistical; mouth neoplasms; odds ratio;
pharyngeal neoplasms; smoking
Abbreviations: BMI, body mass index; EOR, excess odds ratio; INHANCE, International Head and Neck Cancer Epidemiology;
OR, odds ratio.
There is consistent evidence that lower body mass index
(BMI; weight (kg)/height2 (m2)) increases odds ratios for
head and neck cancer (1–10); however, these results are
controversial, since they were derived from case-control
studies and had the potential for differential recall bias of
BMI, reverse causality (i.e., disease-induced changes in
BMI), and incomplete adjustment for cigarette use and al-
cohol consumption, 2 well-documented risk factors (11–
13). In a recent analysis of pooled data from 16 case-control
studies, odds ratios for head and neck cancer were inversely
associated with BMI in all subjects, in never smokers and
drinkers, and in ever smokers and drinkers (10). In this
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report, we further explore BMI-related associations in those
data using models that characterize odds ratios by total ex-
posure (pack-years of smoking and drink-years of alcohol
consumption) and delivery rate (number of cigarettes
smoked per day (cigarettes/day) for fixed pack-years and
number of alcoholic drinks consumed per day (drinks/day)
for fixed drink-years)—that is, increasing exposure rate and
decreasing duration for a fixed total exposure. We consider 2
issues: 1) site-specific differences in odds ratios for cancers
of the larynx, oral cavity, and pharynx by BMI, smoking,
and drinking; and 2) the influence of BMI on site-specific
odds ratios by smoking and alcohol consumption (i.e.,
whether BMI modifies the smoking and alcohol consump-
tion associations). Our analysis represents a formal evalua-
tion of BMI as an effect modifier of the smoking and
drinking associations, particularly whether variations with
BMI derive from total exposure (pack-years or drink-years),
exposure rate (cigarettes/day or drinks/day), or both.
MATERIALS AND METHODS
Study data
We used pooled data from the International Head and
Neck Cancer Epidemiology (INHANCE) Consortium
(http://inhance.iarc.fr/), a consortium of molecular epidemi-
ologic studies of head and neck cancer (10, 14, 15). The
analyses included 15 case-control studies (see Table 1 in
Hashibe et al. (14)), omitting a French study (16) used in
the analysis by Gaudet et al. (10) because it did not enroll
never smokers and an Iowa study (17) because it did not
collect data on BMI, but adding the INHANCE US Multi-
center Study (18).
Cases included invasive tumors classified as cancers of
the oral cavity, oropharynx, hypopharynx, oral cavity or
pharynx, not otherwise specified, or larynx or head and neck
cancer, unspecified. We excluded cancers of the salivary
gland. In their paper, Hashibe et al. (14) provide additional
information on disease classification.
For analyses of BMI and smoking, we restricted data to
never and current smokers of cigarettes only, to eliminate
complications arising from inclusion of former smokers and
users of other tobacco products. We conducted a subgroup
analysis of never smokers and smokers of 10 cigarettes/
day, since previous analyses indicated that light smokers
could distort models because of increased variability from
a limited range of pack-years. For analyses of BMI and
alcohol consumption, we analyzed never drinkers and con-
sumers of 10 drinks/day (95.8% of all controls) and never
drinkers and consumers of 5 drinks/day (86.9% of all
controls), since the small percentage of heavy drinkers con-
tributed to unstable parameter estimates and since use of
these cutpoints resulted in more parsimonious models.
Although it was self-reported, BMI information differed
across studies. The majority of the studies (Milan (Italy),
Aviano (Italy), Italy Multicenter, Switzerland, New York
(New York), Tampa (Florida), Los Angeles (California),
Houston (Texas), Boston (Massachusetts), US Multicenter,
Puerto Rico, Latin America, and International Multicenter)
ascertained BMI at enrollment, while other studies (Central
Europe, New York, Seattle (Washington), Boston, Latin
America, and International Multicenter) sought data on
BMI for 2–5 years prior to enrollment. In the 4 studies
(New York, Latin America, Boston, and International Mul-
ticenter) with both types of BMI data, the Pearson correla-
tion coefficient for BMI at enrollment and BMI 2–5 years
prior was 0.88. Since odds ratio patterns were similar for
BMI at enrollment and BMI 2–5 years prior, we minimized
missing data by using BMI at enrollment if available but
BMI 2–5 years prior if the former was missing.
Statistical models
We fitted linear-exponential models for the excess odds
ratio (EOR) for cancers of the oral cavity, pharynx, and
larynx in total pack-years and cigarettes/day and in total
drink-years and drinks/day as described previously (19).
This approach disassembled the relation between outcome
and total exposure (pack-years or drink-years) and delivery
rate—that is, increasing exposure rate (cigarettes/day or
drinks/day) and decreasing exposure duration (smoking or
drinking) at a fixed total exposure. The approach contrasts
with typical models that include exposure duration and ex-
posure rate, where interpretation is problematic, since odds
ratios by exposure rate with duration held constant neces-
sarily embed the impact of increasing total exposure (15,
19).
We computed odds ratios relative to never smokers for
a cross-classification of pack-years and cigarettes/day and
observed that odds ratios by pack-years increased approxi-
mately linearly within each category of cigarettes/day (15).
For continuous pack-years d, odds ratios (ORs) conformed
to a linear relation—OR(d) ¼ 1 þ ci d—within each cate-
gory (i ¼ 1, . . ., I) of cigarettes/day. Each ci represented the
EOR/pack-year, that is, the strength of the association. The
set of parameters c1, . . ., cI characterized the pack-years
associations and variations by cigarettes/day. For continu-
ous cigarettes/day x, we fitted the model
ORðd; xÞ ¼ 1 þ b d gðxÞ; ð1Þ
where b represents the EOR/pack-year at g(x) ¼ 1 and g(.)
describes the variation of the EOR/pack-year with
cigarettes/day, that is, the influence of delivery rate (19).
While several forms for g(.) fitted adequately, we used
g(x) ¼ exp{u1 ln(x) þ u2 ln(x)2} for consistency with
previous analyses.
We extended model 1 (equation 1) to evaluate effect mod-










where distinct bf parameters and gf (.) functions (i.e., u1f
and u2f) replace b and g(.), and where df equals d and xf
equals x within level f and zero otherwise. In this way,
we assessed whether effect modification resulted from
total exposure (different b’s), exposure rate (different g(.)
functions), or both.
For alcohol consumption, we found approximately linear
increases in the odds ratios for drink-years within categories
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Table 1. Odds Ratios for Cancers of the Oral Cavity, Pharynx, and Larynx According to Body Mass Index, Cigarette Smoking, and Alcohol
Drinking, by Cancer Site, Derived Using Case-Control Data From the International Head and Neck Cancer Epidemiology Consortium
No. of Casesa No. of Controlsa Oral Cavity Pharyx Larynx
Oral Cavity Pharyx Larynx
Oral
Cavity/Pharyxb
Larynx ORc 95% CI ORc 95% CI ORc 95% CI
BMId,e
<18.5 307 205 80 325 150 2.58 2.0, 3.4 2.68 2.0, 3.6 1.69 1.1, 2.5
18.5–24.9f 1,352 1,612 1,011 6,065 4,180 1.00 1.00 1.00
25.0–29.9 651 938 666 6,044 4,533 0.52 0.5, 0.6 0.57 0.5, 0.6 0.63 0.5, 0.7
30.0–34.9 187 259 164 1,827 1,406 0.50 0.4, 0.6 0.52 0.4, 0.6 0.58 0.5, 0.7
35.0–39.9 42 50 39 369 291 0.58 0.4, 0.9 0.46 0.3, 0.7 0.66 0.4, 1.1
40.0 24 25 12 164 136 0.76 0.4, 1.3 0.44 0.3, 0.7 0.60 0.3, 1.3
P for linear trend <0.01 <0.01 <0.01
Pack-yearsg
0f 387 459 107 5,959 4,373 1.00 1.00 1.00
1–29 399 469 282 1,764 1,343 3.19 2.5, 4.0 2.48 2.0, 3.0 7.03 5.1, 9.6
30–39 264 298 264 608 455 5.90 4.3, 8.1 3.35 2.5, 4.4 14.3 9.9, 20.6
40–49 231 283 232 451 324 7.08 4.9, 10.3 3.92 2.8, 5.5 16.8 11.0, 25.5
50–59 166 197 152 247 145 6.91 4.4, 10.8 4.19 2.8, 6.3 23.2 14.0, 38.5
60 425 571 319 473 270 10.1 6.1, 16.7 4.09 2.6, 6.5 21.7 12.3, 38.4
P for linear trend <0.01 <0.01 <0.01
Cigarettes/dayh
1–19f 409 501 413 1,664 1,292 1.00 1.00 1.00
20–29 565 579 486 1,186 833 1.25 1.0, 1.6 1.21 0.9, 1.5 1.54 1.2, 2.0
30–39 188 297 165 324 202 1.08 0.7, 1.7 1.85 1.2, 2.7 1.58 1.0, 2.6
40 323 441 185 369 210 0.98 0.6, 1.6 1.88 1.2, 3.0 1.90 1.1, 3.3
P for linear trend 0.51 0.02 <0.01
Drink-yearsi
0f 658 406 243 4,049 2,783 1.00 1.00 1.00
1–49 774 971 536 5,707 3,766 1.04 0.9, 1.3 1.30 1.1, 1.5 0.98 0.8, 1.2
50–99 359 499 264 1,985 1,594 1.66 1.2, 2.3 1.50 1.1, 2.0 0.94 0.6, 1.4
100–149 247 342 221 1,156 954 2.24 1.5, 3.3 1.41 1.0, 2.0 1.20 0.8, 1.8
150–199 177 274 201 738 628 2.81 1.8, 4.4 1.57 1.1, 2.3 1.35 0.8, 2.2
200 348 597 508 1,159 971 3.22 2.0, 5.2 1.96 1.3, 3.0 1.80 1.1, 3.1
P for linear trend <0.01 <0.01 <0.01
Drinks/dayj
0.01–0.9f 691 704 390 4,420 2,783 1.00 1.00 1.00
1–2.9 563 738 435 3,298 2,571 1.26 1.0, 1.6 1.52 1.3, 1.9 1.05 0.8, 1.4
3.0–4.9 315 498 322 1,590 1,347 1.29 0.9, 1.8 2.30 1.7, 3.1 1.08 0.7, 1.6
5.0–10.0 436 743 583 1,437 1,206 1.87 1.2, 3.9 3.67 2.6, 5.3 1.64 1.0, 2.6
P for linear trend <0.01 <0.01 <0.01
Abbreviations: BMI, body mass index; CI, confidence interval; OR, odds ratio.
a Total numbers vary because of missing data.
b A common control group was used for cancers of the oral cavity and pharynx.
c Adjusted for study/center, education, age, and sex.
d Weight (kg)/height2 (m2).
e Never drinkers and consumers of 10 drinks/day. ORs were additionally adjusted for pack-years of smoking, cigarettes/day, use of other
tobacco products, years since cessation of smoking, drink-years, and drinks/day.
f Reference category.
g Never smokers and current smokers of cigarettes only. ORs were additionally adjusted for BMI, drink-years, drinks/day, and cigarettes/day.
h Never smokers and current smokers of cigarettes only. ORs were additionally adjusted for BMI, drink-years, drinks/day, and pack-years of
smoking.
i Never drinkers and consumers of10 drinks/day. ORs were additionally adjusted for BMI, pack-years of smoking, cigarettes/day, and drinks/day.
j Never drinkers and consumers of10 drinks/day. ORswere additionally adjusted for BMI, pack-years of smoking, cigarettes/day, and drink-years.
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of drinks/day, with the estimated ci parameters increasing
with drinks/day. Model 1 again proved satisfactory for de-
scribing odds ratios but required only u1.
We used polytomous regression to test for homogeneity
of category-specific odds ratios by BMI, smoking, and
drinking across cancer sites.
Analyses were stratified on study/center (39 levels) and age
(<40, 40–44, . . ., 70–74, 75 years), and results were ad-
justed for sex, education (none, some high school, high school
graduation, technical school or some college, college gradu-
ation), and BMI (4 levels). For BMI and smoking, we addi-
tionally adjusted for drink-years (never drinking and quartiles
of drink-years) and drinks/day (never drinking and <1.0, 1.0–
2.9, 3.0–4.9, or 5.0 drinks/day). For BMI and alcohol con-
sumption, we additionally adjusted for pack-years of smoking
(never smoking and quartiles of pack-years) and cigarettes/
day (never smoking and <20, 20–29, 30–39, or 40
cigarettes/day) and use of other tobacco products.
We used the Epicure software package for fitting models
1 and 2 (20) and SAS, version 9.1, for polytomous regres-
sion analyses (SAS Institute, Inc., Cary, North Carolina).
RESULTS
For analyses of BMI and smoking, there were 1,872 cases
of oral cavity cancer, 2,277 cases of pharynx cancer, and
1,356 cases of larynx cancer. Controls numbered 9,502 for
cases of oral cavity and pharynx cancer and 6,910 for cases
of larynx cancer. Four studies (New York, Seattle, Puerto
Rico, and International Multicenter) did not enroll laryngeal
cancers, leading to fewer controls. For analyses of BMI and
alcohol consumption, there were 2,563 cases of oral cavity
cancer, 3,089 cases of pharynx cancer, and 1,972 cases of
larynx cancer. Controls numbered 14,794 for cases of oral
cavity and pharynx cancer and 10,696 for cases of larynx
cancer. As described below, we combined oral cavity and
pharyngeal cancers and included 828 cases classified as
cancer of the oral cavity/pharynx not otherwise specified.
Odds ratios for BMI, smoking, and drinking
For each site, odds ratios relative to normal weight (BMI
18.5–24.9) were increased in underweight categories and
decreased in the overweight categories, with the lowest odds
ratios generally occurring in obese categories (BMI 30)
(Table 1).
Odds ratios by pack-years of smoking were increased for
all sites, with the greatest trend being observed for laryngeal
cancer (Table 1). Odds ratios for 60 pack-years of smoking
relative to never smoking were 10.1 for oral cavity cancer,
4.09 for pharynx cancer, and 21.7 for larynx cancer. After
adjustment for pack-years of smoking, odds ratios by ciga-
rettes/day relative to 1–19 cigarettes/day were increased
significantly for pharyngeal and laryngeal cancers.
Odds ratios by drink-years were increased for all sites,
with trends being greater for oral cavity and pharyngeal
cancers. After adjustment for drink-years, odds ratios by
drinks/day relative to less than 1 drink/day increased mono-
tonically with drinks/day, suggesting that increasing number
of drinks/day strengthened the drink-years association.
Although Table 1 suggested that odds ratios for oral cav-
ity cancer, as compared with pharyngeal cancer, were
greater for pack-years and drink-years but smaller for ciga-
rettes/day and drinks/day, hypothesis tests using polytomous
regression did not reject homogeneity of odds ratios for the
2 sites by BMI (P ¼ 0.65), pack-years and cigarettes/day
(P ¼ 0.52), or drink-years and drinks/day (P ¼ 0.73) (data
not shown). Odds ratios for cancers of the oral cavity and
pharynx combined differed significantly from odds ratios
for laryngeal cancer by BMI (P < 0.01), smoking (P <
0.01), and drinking (P < 0.01). For the remaining analyses,
we combined oral cavity and pharyngeal cancer cases.
Modification of pack-years and cigarettes/day effects
by BMI
Figure 1 shows odds ratios by pack-years and by ciga-
rettes/day within BMI categories, omitting 95% confidence
intervals for clarity, to illustrate effect modification. (See
Web Table 1, which is posted on the Journal’s Web site
(http://aje.oxfordjournals.org/), for odds ratios.) Odds ratio
trends for cancers of the oral cavity/pharynx by pack-years
and by cigarettes/day were generally greater with lower
BMI (Figure 1, section A, top and bottom panels), while
odds ratio trends for laryngeal cancer by pack-years and
by cigarettes/day were unrelated to BMI (Figure 1, section
B, top and bottom panels).
We used model 2 (equation 2) with pack-years and ciga-
rettes/day to evaluate effect modification by BMI, both vi-
sually (Figure 2 and Web Table 2) and formally using
likelihood ratio tests (Table 2). Model 2 closely fitted the
cigarettes/day category-specific EOR/pack-year estimates
(ci) (Figure 2, square symbol). Within each BMI category,
the pack-years association (i.e., the EOR/pack-year esti-
mates) diminished with increasing delivery rate above 15
cigarettes/day—that is, for fixed pack-years, a higher num-
ber of cigarettes/day for a shorter duration was less delete-
rious than a lower number of cigarettes/day for a longer
duration.
For oral cavity/pharyngeal cancer, EOR/pack-year esti-
mates were higher in lower BMI categories (Table 2, P <
0.01). In smokers of 10 cigarettes/day, evaluation of effect
modification of pack-years by BMI (P ¼ 0.82) and of cig-
arettes/day by BMI (P ¼ 0.29) revealed no preferential in-
teraction. For laryngeal cancer, smoking associations varied
significantly by BMI in the full data (P < 0.01); however,
EOR/pack-year patterns exhibited no significant variation
with BMI among smokers of 10 cigarettes/day (Table 2,
P ¼ 0.08; P ¼ 0.15 for subjects with BMI 18.5). Finally,
EOR/pack-year estimates were consistently greater for la-
ryngeal cancer than for oral cavity/pharyngeal cancer, ex-
cept among subjects with BMI less than 18.5, where data
were limited (Figure 2).
Modification of drink-years and drinks/day effects
by BMI
Except for BMI less than 18.5, odds ratios for oral cavity/
pharyngeal cancer by drink-years and by drinks/day within
BMI categories were consistently greater at lower BMIs
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(Figure 3, section A, top and bottom panels). For laryngeal
cancer, odds ratios by drink-years and by drinks/day were
similar across BMI categories (Figure 3, section B, top and
bottom panels). (See Web Table 3 for odds ratios.)
Within each BMI category, the EOR/drink-year estimates
and the fitted model 2 increased with increasing number of
drinks/day, indicating that the strength of the disease associa-
tion by drink-years increased with increasing drinks/day
(Figure 4 and Web Table 4). The EOR/drink-year patterns
for oral cavity/pharyngeal cancer were enhanced with decreas-
ing BMI, while the patterns for laryngeal cancer did not vary
with BMI, except possibly in the lowest BMI category.
For oral cavity/pharyngeal cancer, the EOR/drink-year
patterns were significantly greater in leaner subjects
(Table 3, P < 0.01). Effect modification resulted from the
interaction between drink-years and BMI, while the impact
of drinks/day was homogeneous across BMI. For example,
with the 5 drinks/day restriction, homogeneity of the in-
teraction between drink-years and BMI with adjustment for
the interaction between drinks/day and BMI was rejected
(P ¼ 0.02), while homogeneity of the interaction between
drinks/day and BMI with adjustment for the interaction be-
tween drink-years and BMI was not rejected (P¼ 0.85). For
laryngeal cancer, BMI did not modify alcohol-related asso-
ciations (Table 3; P¼ 0.59 in subjects with BMI 18.5, and
P ¼ 0.76 and P ¼ 0.92 in consumers of 5 drinks/day
overall and in data restricted to subjects with BMI 18.5,
respectively).
Study-specific results
Increasing odds ratios with lower BMIs were generally
consistent across studies (results not shown). The 10 studies
including both oral cavity/pharyngeal and laryngeal cancers
and the 5 studies including oral cavity/pharyngeal cancers
only generated 25 parameter estimates for ln(BMI). There
were 23 negative estimates of the ln(BMI) parameter, with
16 being statistically significant, and 2 nonsignificantly pos-
itive estimates. Odds ratios with BMI were steeper for oral
cavity/pharyngeal cancer than for laryngeal cancer. In stud-
ies including both case types, 9 of 10 parameter estimates
for ln(BMI) were smaller for oral cavity/pharynx cancers,
indicating a steeper trend in odds ratios, with 3 tests of
homogeneity being rejected.















































Figure 1. Odds ratios for oral cavity/pharyngeal cancer (section A, top and bottom panels) and laryngeal cancer (section B, top and bottom
panels) within categories of body mass index (BMI; weight (kg)/height2 (m2)), by pack-years of cigarette smoking (relative to never smoking) and by
number of cigarettes smoked per day (relative to 1–19 cigarettes/day). n, BMI <18.5; d, BMI 18.5–24.9; :, BMI 25.0–29.9; ;, BMI 30. Odds
ratios were adjusted for sex, study/center, age, education, drink-years, drinks/day, BMI, and the complementary smoking factor, cigarettes/day or
pack-years. Data were pooled data obtained from the International Head and Neck Cancer Epidemiology (INHANCE) Consortium and were limited
to never smokers and current smokers of cigarettes only.
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We evaluated study-specific interactions between smok-
ing and BMI by adding ln(BMI) to g(.) in model 1. Among
never smokers and smokers of 10 cigarettes/day and for
oral cavity/pharyngeal cancer, all parameter estimates were
negative, denoting an inverse association—that is, an in-
creasing magnitude of the effect of smoking with decreasing
BMI, with 8 of 15 tests being statistically significant. For
laryngeal cancer, the estimated parameter for ln(BMI) was
negative for 5 studies and positive for 5 studies, with all
hypothesis tests being nonsignificant. Study-specific results
were thus consistent with pooled results, indicating an in-
teraction between smoking and BMI for oral cavity/pharyn-
geal cancer but not for laryngeal cancer.
For the study-specific interaction between drinking and
BMI and for oral cavity/pharyngeal cancer, all parameter
estimates for ln(BMI) were negative, and 14 of 15 tests were
significant. For laryngeal cancer, 8 of 10 parameter esti-
mates were negative, with 4 being significant. The study-
specific results were consistent with pooled results in
suggesting an inverse association—that is, an increasing
Figure 2. Estimated excess odds ratios (EORs) per pack-year of cigarette smoking for oral cavity/pharyngeal cancer (section A) and laryngeal
cancer (section B), according to number of cigarettes smoked per day (n), within categories of body mass index (weight (kg)/height2 (m2); <18.5,
18.5–24.9, 25.0–29.9, and 30 from top panel to bottom panel, respectively). The curved lines show results from model 1 for never smokers and
current smokers of cigarettes only (solid line) and never smokers and smokers of10 cigarettes/day (dashed line). Data were pooled data obtained
from the International Head and Neck Cancer Epidemiology (INHANCE) Consortium and were limited to never smokers and current smokers of
cigarettes only. Bars represent 95% confidence intervals.
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Table 2. Results From Modelinga of Excess Odds Ratios for Cancers of the Oral Cavity, Pharynx, and Larynx According to Cigarette Smoking (Pack-Years and Cigarettes/Day), by Body
Mass Index Category, Derived Using Case-Control Data From the International Head and Neck Cancer Epidemiology Consortium
Variable
Oral Cavity and Pharyngeal Cancer Cases and Controls Laryngeal Cancer Cases and Controls
Parameter Estimate Effect Modification by BMIb Parameter Estimate Effect Modification by BMI
bf u1f u2f BMI Times:
c DDeviance (no.)d P Valuee bf u1f u2f BMI Times:
c DDeviance (no.)d P Valuee
Never Smokers and Current Smokers of Cigarettes Only
Total 0.0170 1.436 0.270 0.2811 0.270 0.025
BMI
<18.5 0.0184 2.889 0.635 Both 0 (12) 67.30 2.845 0.335 Both 0 (12)
18.5–24.9 0.3441 0.262 0.006 Cigarettes/day 10.2 (9) 0.02 0.5546 0.121 0.057 Cigarettes/day 18.9 (9) <0.01
25.0–29.9 0.0003 3.647 0.593 Pack-years 14.3 (6) 0.03 0.1238 0.925 0.162 Pack-years 25.6 (6) <0.01
30 0.0015 2.192 0.345 None 72.5 (3) <0.01 4.70 3 1011 13.54 1.942 None 29.7 (3) <0.01
BMI (omitting <18.5)
18.5–24.9 0.3971 0.334 0.017 Both 0 (9) 0.5783 0.176 0.072 Both 0 (9)
25.0–29.9 0.0003 3.567 0.581 Cigarettes/day 11.0 (7) <0.01 0.1535 0.768 0.132 Cigarettes/day 14.5 (7) <0.01
30 0.0014 2.228 0.347 Pack-years 8.3 (5) 0.08 3.64 3 109 13.68 1.962 Pack-years 16.8 (5) <0.01
None 60.4 (3) <0.01 None 18.8 (3) <0.01
Never Smokers and Current Smokers of 10 Cigarettes/Day
Total 0.0019 2.779 0.470 0.0004 4.314 0.645
BMI
<18.5 0.4099 0.940 0.388 Both 0 (12) 105.80 2.615 0.220 Both 0 (12)
18.5–24.9 0.0027 2.758 0.453 Cigarettes/day 0.9 (9) 0.82 0.0092 2.411 0.327 Cigarettes/day 6.9 (9) 0.08
25.0–29.9 0.0004 3.388 0.557 Pack-years 7.4 (6) 0.29 0.0001 5.138 0.805 Pack-years 12.3 (6) 0.08
30 0.0103 1.093 0.189 None 64.4 (3) <0.01 7.70 3 1011 13.19 1.884 None 15.3 (3) 0.08
BMI (omitting <18.5)
18.5–24.9 0.0031 2.668 0.440 Both 0 (9) 0.0092 2.383 0.317 Both 0 (9)
25.0–29.9 0.0005 3.293 0.541 Cigarettes/day 0.3 (7) 0.88 0.0001 5.114 0.799 Cigarettes/day 5.8 (7) 0.06
30 0.0062 1.384 0.229 Pack-years 0.5 (5) 0.98 6.85 3 108 13.27 1.898 Pack-years 7.8 (5) 0.10
None 52.5 (3) <0.01 None 9.5 (3) 0.15
Abbreviations: BMI, body mass index; EOR, excess odds ratio.
a Model: EOR ¼ bf d gf (x), with g(x) ¼ exp{u1 ln(x) þ u2 ln(x)2}, where d is pack-years and x is cigarettes/day. The subscript (f) denotes separate effects for levels of BMI. Results were
adjusted for study/center, education, age, sex, BMI, drink-years, and drinks/day.
b Weight (kg)/height2 (m2).
c Effect modification of BMI by smoking, including: ‘‘both,’’ modification of BMI by pack-years and of BMI by cigarettes/day, bf d gf (x); ‘‘cigarettes/day,’’ modification of BMI by cigarettes/day,
b d gf (x); ‘‘pack-years,’’ modification of BMI by pack-years, bf d g(x); and ‘‘none,’’ no effect modification, b d g(x).
d Deviance change relative to the 12-parameter model bf d gf (x) and (in parentheses) number of parameters in the EOR.







































magnitude of the effects of drinking with decreasing BMI,
primarily in oral cavity/pharyngeal cases.
DISCUSSION
In previous analyses of these data (10), as well as analyses
by other investigators (1–9), researchers have reported
increasing odds ratios for head and neck cancer with in-
creasing leanness. In addition, analyses have indicated ho-
mogeneity of smoking-related and alcohol-related patterns
of association for oral cavity and pharyngeal cancers (9, 15).
Our analysis of 15 case-control studies extended these
observations in several important ways, suggesting that:
1) trends in odds ratios with BMI, as well as smoking and
drinking, were homogeneous for oral cavity and pharyngeal
cancers; 2) the trend in odds ratios with lower BMI was
greater for oral cavity/pharyngeal cancer than for laryngeal
cancer; 3) leanness significantly enhanced smoking- and
alcohol-related associations for oral cavity/pharyngeal can-
cer but did not modify smoking- and alcohol-related asso-
ciations for laryngeal cancer; and 4) the modification of
associations between alcohol and oral cavity/pharyngeal
cancer by BMI was derived from differential effects of
drink-years, with the relative effects of delivery rate (in-
creasing drinks/day with decreasing duration) being homo-
geneous by BMI.
Precise biologic mechanisms for the association between
head and neck cancers and BMI are unknown, but they may
involve altered calorie absorption and utilization, increased
oxidative stress (21, 22), and increased numbers of DNA
adducts (10). Since in our analysis odds ratios increased
with low BMI in never drinkers and never smokers (10),
as well as after extensive adjustment for smoking and drink-
ing, the disease-related influence of BMI appears at least
partially distinct from mechanisms involving smoking and
drinking. However, since lower BMI significantly enhanced
smoking- and alcohol-related associations for oral cavity/
pharyngeal cancer but not for laryngeal cancer, there must
be additional site-specific factors which uniquely associate
BMI and oral cavity/pharyngeal cancer that explain the
BMI-related enhancements. These associations may be in-
direct. For example, lower BMI has been associated with
tooth loss (23, 24) and altered oral bacterial flora, which
may lead to increased production of acetaldehyde or other














































Figure 3. Odds ratios for oral cavity and pharyngeal cancer (section A, top and bottom panels) and laryngeal cancer (section B, top and bottom
panels) within categories of body mass index (weight (kg)/height2 (m2)), by drink-years of alcohol consumption (relative to never drinking) and by
number of drinks consumed per day (relative to 0.01–0.99 drinks/day). n, BMI <18.5; d, BMI 18.5–24.9; :, BMI 25.0–29.9; ;, BMI 30. Odds
ratios were adjusted for sex, study/center, age, education, pack-years of smoking, cigarettes/day, years since smoking cessation, use of other
tobacco products, BMI, and the complementary drinking factor, drinks/day or drink-years. Data were pooled data obtained from the International
Head and Neck Cancer Epidemiology (INHANCE) Consortium and were limited to never drinkers and consumers of 10 drinks/day.
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carcinogens, thereby enhancing exposure effects for cancer
of the oral cavity/pharynx (25, 26). However, the absence of
effect modification of alcohol-related risks for laryngeal
cancer by BMI may have resulted from the relatively small
overall alcohol-related odds ratios for laryngeal cancer.
For oral cavity/pharyngeal cancer, modification of the
effect of alcohol consumption by BMI was specific, with
BMI modifying the drink-years association (different b’s),
while the influence of delivery rate (drinks/day) was homo-
geneous by BMI (i.e., similar g(.) functions). Thus, lower
BMI increased the strength of the relation between oral
cavity/pharyngeal cancer and drink-years, but the relative
impacts of delivery rate on the relation between disease and
drink-years were proportionally similar at all BMI levels.
This result parallels that of our previous analysis, which
found that the increased odds ratios for oral cavity/pharyn-
geal cancer with alcohol consumption as compared
with laryngeal cancer were due to effects of drink-years,
with drinks/day effects being homogeneous across cancer
sites (15).
Ethanol may enhance the permeability of cells to environ-
mental carcinogens, notably tobacco smoke (11, 12, 27, 28).
Figure 4. Estimated excess odds ratios (EORs) per drink-year of alcohol consumption for oral cavity/pharyngeal cancer (section A) and laryngeal
cancer (section B) according to number of drinks consumed per day (n), within categories of body mass index (weight (kg)/height2 (m2); <18.5,
18.5–24.9, 25.0–29.9, and 30 from top panel to bottom panel, respectively). The curved line shows results from model 1 for subjects consuming
10 drinks/day. Data were pooled data obtained from the International Head and Neck Cancer Epidemiology (INHANCE) Consortium and were
limited to never drinkers and consumers of 10 drinks/day. Bars represent 95% confidence intervals.
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Table 3. Results FromModelinga of Excess Odd Ratios for Cancers of the Oral Cavity, Pharynx, and Larynx According to Alcohol Consumption (Drink-Years and Drinks/Day), by Body Mass
Index Category, Derived Using Case-Control Data From the International Head and Neck Cancer Epidemiology Consortium
Variable
Oral Cavity and Pharyngeal Cancer Cases and Controls Laryngeal Cancer Cases and Controls
Parameter Estimate Effect Modification by BMIb Parameter Estimate Effect Modification by BMI
bf u1f BMI Times:
c DDeviance (no.)d P Valuee bf u1f BMI Times:
c DDeviance (no.)d P Valuee
Never Drinkers and Consumers of 10 Drinks/Day
Total 0.0113 0.248 0.0004 1.440
BMI
<18.5 0.0033 1.761 Both 0 (8) 4.54 3 105f 3.110 Both 0 (8)
18.5–24.9 0.0189 0.177 Drinks/day 14.0 (5) <0.01 9.65 3 105 2.045 Drinks/day 12.5 (5) 0.01
25.0–29.9 0.0058 0.448 Drink-years 9.3 (5) 0.03 0.0005 1.342 Drink-years 12.8 (5) 0.01
30 0.0055 0.116 None 58.9 (2) <0.01 0.0024 0.688 None 15.1 (2) 0.02
BMI (omitting <18.5)
18.5–24.9 0.0182 0.202 Both 0 (6) 0.0001 2.011 Both 0 (6)
25.0–29.9 0.0059 0.447 Drinks/day 11.4 (4) <0.01 0.0005 1.330 Drinks/day 2.2 (4) 0.33
30 0.0055 0.126 Drink-years 1.6 (4) 0.46 0.0024 0.681 Drink-years 1.8 (4) 0.42
None 43.5 (2) <0.01 None 2.8 (2) 0.59
Never Drinkers and Consumers of 5 Drinks/Day
Total 0.0127 0.192 0.0007 0.946
BMI
<18.5 0.0122 0.657 Both 0 (8) 0.0136 1.510 Both 0 (8)
18.5–24.9 0.0205 0.199 Drinks/day 10.3 (5) 0.02 0.0006 1.204 Drinks/day 1.3 (5) 0.72
25.0–29.9 0.0092 0.110 Drink-years 0.8 (5) 0.85 3.58 3 105 2.838 Drink-years 2.7 (5) 0.45
30 0.0041 0.271 None 37.5 (2) <0.01 0.0032 0.057 None 3.4 (2) 0.76
BMI (omitting <18.5)
18.5–24.9 0.0193 0.244 Both 0 (6) 0.0006 1.179 Both 0 (6)
25.0–29.9 0.0093 0.110 Drinks/day 8.8 (4) 0.01 1.29 3 105 3.482 Drinks/day 0.8 (4) 0.69
30 0.0041 0.290 Drink-years 0.3 (4) 0.87 0.0038 0.056 Drink-years 0.7 (4) 0.72
None 34.9 (2) <0.01 None 1.0 (2) 0.92
Abbreviations: BMI, body mass index; EOR, excess odds ratio.
a Model: EOR ¼ bf d gf (x), with g(x) ¼ exp{u1 ln(x)}, where d is drink-years and x is drinks/day. The subscript (f) denotes separate effects for levels of BMI. Results were adjusted for study/
center, education, age, sex, pack-years of smoking, cigarettes/day, years since cessation of smoking, and use of other tobacco products.
b Weight (kg)/height2 (m2).
c Effect modification of BMI by alcohol drinking, including: ‘‘both,’’ modification of BMI by drink-years and of BMI by drinks/day, bf d gf (x); ‘‘drinks/day,’’ modification of BMI by drinks/day,
b d gf (x); ‘‘drink-years,’’ modification of BMI by drink-years, bf d g(x); and ‘‘none,’’ no effect modification, b d g(x).
d Deviance change relative to the 8-parameter model bf d gf (x) and (in parentheses) number of parameters in the EOR.
e P value from a likelihood ratio test relative to bf d gf (x), which included BMI modification for drink-years and drinks/day.







































































Ethanol is oxidized to acetaldehyde, a human carcinogen
(group 1) (29), through the enzymatic activity of alcohol
dehydrogenase and, to a lesser extent, cytochrome P-450
enzymes, including cytochrome P-450 2E1, while acetal-
dehyde is metabolized by aldehyde dehydrogenase to ace-
tate (30). Since this process occurs primarily in the liver and
stomach (27, 30), the increased odds ratios with alcohol
consumption for oral cavity/pharyngeal cancer as com-
pared with laryngeal cancer suggest that site-specific fac-
tors must play a role (13–15, 27, 31–33). These factors may
include increased production of acetaldehyde due to oral
bacterial flora (28) or poor dentition, which may increase
the release of proinflammatory cytokines (34) or enhance
the effects of bacterial flora (25, 26). The extent to which
BMI influences ethanol metabolism directly or indirectly is
unknown.
The consistency of the effects of increased BMI, smok-
ing, and alcohol drinking on oral cavity, pharyngeal, and
laryngeal cancer for underweight subjects in this analysis
and other studies (1–9), the similarity of results based on
current BMI and results based on BMI 2–5 years prior (10),
and the differential BMI effect modification for cancers of
the oral cavity/pharynx as compared with larynx cancer
suggest that our results were not due to misclassification
or to disease-induced weight loss. It is also unlikely that
residual confounding from incomplete adjustment for
smoking and/or alcohol consumption explains the effect
modification patterns. In our analysis, the smoking- and
alcohol-adjusted odds ratios for BMI less than 18.5 relative
to a BMI of normal range (18.5–24.9) were 2.6, 2.7, and 1.7
for oral cavity, pharynx, and larynx cancers, respectively
(Table 1), which were similar to the 2.5- to 3-fold increased
odds ratios for head and neck cancer observed previously
among never smokers and never drinkers (10), suggesting
that our analyses substantially controlled for confounding
from smoking and alcohol consumption. BMI was an inde-
pendent risk factor for cancers of the oral cavity/pharynx and
larynx but a modifier of smoking- and alcohol-related risk
only for cancers of the oral cavity/pharynx. The complexity
of these associations makes it unlikely that misclassification
drove the results, since biases would have had to differ by
cancer site. In addition, odds ratios for alcohol consumption
were small relative to those for cigarette smoking, and thus
residual confounding from drinking would be insufficient to
induce the BMI effect modification of smoking effects.
In summary, odds ratios for low BMI and greater smoking
and drinking were increased for all sites and were homoge-
neous for oral cavity and pharyngeal cancers. Associations
between alcohol drinking and BMI were greater for oral
cavity/pharyngeal cancer, while associations between smok-
ing and BMI were greater for laryngeal cancer. Low BMIs
significantly enhanced smoking- and alcohol-related effects,
but only for oral cavity/pharyngeal cancer. The increased
odds ratios for all sites with low BMI suggest related causal
mechanisms, while the modification of the smoking and
drinking associations by BMI for oral cavity/pharyngeal
cancer but not laryngeal cancer suggests additional factors
which are unique to oral cavity/pharyngeal cancer. Precise
causal mechanisms remain to be elucidated. The ability to
conduct detailed analyses using large numbers of case sub-
jects highlights the importance of large-scale collaborations
such as the INHANCE Consortium.
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25. Pöschl G, Seitz HK. Alcohol and cancer. Alcohol Alcohol.
2004;39(3):155–165.
26. Homann N, Tillonen J, Meurman JH, et al. Increased salivary
acetaldehyde levels in heavy drinkers and smokers: a micro-
biological approach to oral cavity cancer. Carcinogenesis.
2000;21(4):663–668.
27. Marshall JR, Freudenheim J. Alcohol. In: Schottenfeld D,
FraumeniJF Jr, eds. Cancer Epidemiology and Prevention.
3rd ed. New York, NY: Oxford University Press; 2006:243–
258.
28. Seitz HK, Becker P. Alcohol metabolism and cancer risk. Al-
cohol Res Health. 2007;30(1):38–47.
29. Baan R, Straif K, Grosse Y, et al. Carcinogenicity of alcoholic
beverages. Lancet Oncol. 2007;8(4):292–293.
30. Zakhari S. Overview: how is alcohol metabolized by the body?
Alcohol Res Health. 2006;29(4):245–254.
31. Hashibe M, McKay JD, Curado MP, et al. Multiple ADH genes
are associated with upper aerodigestive cancers. Nat Genet.
2008;40(6):707–709.
32. Zeka A, Gore R, Kriebel D. Effects of alcohol and tobacco on
aerodigestive cancer risks: a meta-regression analysis. Cancer
Causes Control. 2003;14(9):897–906.
33. Corrao G, Bagnardi V, Zambon A, et al. A meta-analysis of
alcohol consumption and the risk of 15 diseases. Prev Med.
2004;38(5):613–619.
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